13F Pro Quality Score

52.4/100

Rank #1,347 of 2,879 stocksTOP 50%

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

38.2/100

Profitability

58.7/100

Balance Sheet

48.3/100

Earnings Quality

6.0/100

Free Cash Flow

73.8/100

Institutional Flow

19.3/100

Revenue Scale

68.3/100

Dilution Risk

63.2/100

RVTY Stock Analysis & AI Quality Score

AI stock analysis and institutional research for REVVITY, INC. (RVTY), a Technology sector company. 13F Pro's AI-powered ranking engine scores RVTY at 52.4/100 on a 32-signal composite quality model, placing it at rank #1,347 of 2,879 stocks — the top half of the AI-ranked universe. Areas of concern include earnings quality (6.0) and institutional flow (19.3), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), REVVITY, INC. reports quarterly revenue of $711.1M, net income of $40.7M, an operating margin of 10.7%. Top institutional holders of RVTY by reported 13-F value include EdgePoint Investment Group, JANUS HENDERSON GROUP PLC, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. RVTY trades on the NYSE exchange and files with the SEC under CIK 31791. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RVTY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for REVVITY, INC. directly from SEC EDGAR. REVVITY, INC.'s 13F Pro composite quality score has ranged between 8 and 60 since 2023, currently 52.4 — a declining long-term trajectory across 47 quarterly and live scoring snapshots.

Fun facts about REVVITY, INC.

Quirks, history, and lore behind RVTY — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. life sciences technology company · mid-cap · listed on Nasdaq · headquartered in Massachusetts.
  • 2
    The Numbers
    Annual revenue in the range of roughly $2–3 billion, with operations spanning more than 30 countries and thousands of employees worldwide.
  • 3
    The History
    The company you know today emerged from the 2023 rebranding of a storied scientific instruments giant, shedding a legacy name that had been around since the 1930s.
  • 4
    The Secret
    It spun off its industrial and environmental testing business to focus purely on human and environmental health — diagnostics, genomics, and drug discovery tools.
  • 5
    The Lore
    Its predecessor, PerkinElmer, was itself the product of a merger between two venerable scientific firms — one of which traces its roots to Nobel laureate Emilio Segrè's era of atomic science.
  • 6
    The Giveaway
    Formerly traded as PerkinElmer, it rebranded with a snappy new name and ticker to signal its pure-play focus on life science diagnostics and tools — the old name is gone, but the pipettes remain.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$711.1M

Net Income

Q1 2026

$40.7M

Free Cash Flow

Q1 2026

$95.5M

Operating Margin

Q1 2026

10.7%

ROIC

Q1 2026

0.8%

D/E Ratio

Q1 2026

0.45

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-28.1% YoY
$2.75BFY 2023
FY19 $2.88BFY20 $3.78BFY21 $3.83BFY23 $2.75B

Net Income

-26.5% YoY
$693.1MFY 2023
FY19 $227.6MFY20 $727.9MFY21 $943.2MFY23 $693.1M

Operating Income

-76.1% YoY
$300.6MFY 2023
FY19 $362.0MFY20 $867.3MFY21 $1.26BFY23 $300.6M

EPS (Diluted)

-31.3% YoY
$5.55FY 2023
FY19 $2.04FY20 $6.49FY21 $8.08FY23 $5.55

Total Assets

-9.6% YoY
$13.56BFY 2023
FY19 $6.54BFY20 $7.96BFY21 $15.00BFY23 $13.56B

Total Debt

-21.9% YoY
$3.93BFY 2023
FY19 $2.08BFY20 $2.01BFY21 $5.03BFY23 $3.93B

Op. Cash Flow

-93.5% YoY
$91.3MFY 2023
FY19 $363.5MFY20 $892.2MFY21 $1.41BFY23 $91.3M

AI Insight: RVTY Financial Trends

Revenue volatility persists while operating cash flow deteriorates to lowest level in two years.

Operating cash flow declined to $115M in Q2 2026 from $182M in Q4 2025, a 37% drop in six months.

Net income fell to $41M in Q2 2026 from $98M in Q4 2025, reverting to weakest profitability levels.

Debt stable near $3.2B across last four quarters while equity contracted 6% from Q2 2025 to Q2 2026.

Revenue remains volatile with no discernible trend; Q2 2026 at $711M sits midrange of past eight quarters.

Operating margin compressed to 10.7% in Q2 2026 from 14.5% in Q4 2025, lowest quarterly level in dataset.

AI Insight: RVTY Ratio Trends

Profitability collapsed in Q2 2026 — operating margin fell to 10.7%, NPM to 5.7%, the lowest levels in the dataset.

Operating margin declined from 14.5% in Q4 2025 to 10.7% in Q2 2026; net profit margin fell from 12.7% to 5.7%.

ROIC dropped to 2.9% in Q2 2026 from 4.3% in Q4 2025, reversing a modest recovery from Q1 2025 lows.

Leverage holding steady at 0.45 D/E; balance sheet structure unchanged despite earnings pressure.

Earnings power eroded significantly in first half of 2026 — both margins and returns at or near multi-year lows.

Pattern of Q1–Q2 weakness repeating: Q1 2025 and Q1 2026 both showed sharp profit declines vs. prior-year Q4.

Get alerted when RVTY's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for REVVITY, INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of RVTY

Put RVTY on your watchlist

Track score changes the day REVVITY, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is RVTY a good stock to buy?

13F Pro's AI-powered analysis of REVVITY, INC. (RVTY) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for RVTY are available on the RVTY stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own RVTY?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling RVTY. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of REVVITY, INC.'s investment landscape.